Micreos wins FSANZ approval for phage product Salmonelex against Salmonella.
M2 EQUITYBITES-May 30, 2016-Micreos wins FSANZ approval for phage product Salmonelex against Salmonella
(C)2016 M2 COMMUNICATIONS http://www.m2.com
Antibacterial technology company Micreos announced on Monday the receipt of approval from the Food Standards Australia/New Zealand (FSANZ) for Salmonelex as a processing aid against salmonella.
The company added that Salmonelex is the second phage product for food safety accepted in Australia and New Zealand after an earlier approval of Listex against Listeria monocytogenes. It is produced by Micreos of The Netherlands, a provider of phage technology. Phages are micro-organisms that are harmless to humans, animals and plants and are naturally present in high numbers on our skin, in our gut, in our environment, in our water and many of our foods.
According to the company, Salmonelex is misted onto the surface and kills Salmonella without any sensory effects and is certified organic. As a processing-aid it does not require labeling. With approvals in the USA, it may now be used in Aus/NZ to control Salmonella on meat and poultry products.
Salmonella is one of the most commonly reported causes of foodborne illness, with raw fresh meat and poultry often implicated as a source of infection. Fresh raw meat and poultry can be contaminated with Salmonella, which can cause illness if meat is consumed under-cooked or if cross contamination occurs during handling and preparation.
Phage technology is reportedly set to replace antibiotics and chemicals in many applications, as it can be used for targeted control of only unwanted bacteria. Phages are essential for life on earth and kill roughly half of all bacteria on the planet every two days.
((Comments on this story may be sent to firstname.lastname@example.org))